Document Mentions (4 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

plaints were phishing and similar ploys, non-payment/non-delivery scams, and extortion." DHS CIO Describes New Network Incident Response Strategy. FedScoop <https://www.fedscoop.com/dhs-nosc-karen-evans/> (9/30, Nyczepir) reports DHS is consolidating its "network and security operations centers to ensur

EFTA00135712

2 mentions1 same-page

Page ?Same page

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

plaints were phishing and similar ploys, non-payment/non-delivery scams, and extortion." DHS CIO Describes New Network Incident Response Strategy. FedScoop (9/30, Nyczepir) reports DHS is consolidating its "network and security operations centers to ensure services remain available when analysts must in

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human